View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
GRIFFIN - Bortezomib 1.3 / Daratumumab 1800 / Lenalidomide 25 / Dexamethasone 20, multiple myeloma, induction, cycle 1-4
Protocol-ID: 1723 V1.2 (Mini), GRIFFIN - BORT1.3/DRTM1800/LENA25/DEXA20, MM, ind., C1-4Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 05.05.2026
